Upstream Bio Stock Forecast - Naive Prediction
| UPB Stock | 31.79 0.20 0.63% |
The Naive Prediction forecasted value of Upstream Bio on the next trading day is expected to be 33.60 with a mean absolute deviation of 1.03 and the sum of the absolute errors of 62.65. Upstream Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Upstream Bio stock prices and determine the direction of Upstream Bio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Upstream Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Upstream Bio's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.79) | EPS Estimate Current Year (2.70) | EPS Estimate Next Year (3.21) | Wall Street Target Price 49.75 | EPS Estimate Current Quarter (0.78) |
Using Upstream Bio hype-based prediction, you can estimate the value of Upstream Bio from the perspective of Upstream Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Upstream Bio using Upstream Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Upstream using crowd psychology based on the activity and movement of Upstream Bio's stock price.
Upstream Bio Implied Volatility | 1.84 |
Upstream Bio's implied volatility exposes the market's sentiment of Upstream Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Upstream Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Upstream Bio stock will not fluctuate a lot when Upstream Bio's options are near their expiration.
The Naive Prediction forecasted value of Upstream Bio on the next trading day is expected to be 33.60 with a mean absolute deviation of 1.03 and the sum of the absolute errors of 62.65. Upstream Bio after-hype prediction price | USD 31.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Upstream Bio to cross-verify your projections. Prediction based on Rule 16 of the current Upstream contract
Based on the Rule 16, the options market is currently suggesting that Upstream Bio will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-03-20 option contract. With Upstream Bio trading at USD 31.79, that is roughly USD 0.0366 . If you think that the market is fully incorporating Upstream Bio's daily price movement you should consider acquiring Upstream Bio options at the current volatility level of 1.84%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Upstream Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Upstream Bio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Upstream Bio's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Upstream Bio stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Upstream Bio's open interest, investors have to compare it to Upstream Bio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Upstream Bio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Upstream. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Upstream Bio Additional Predictive Modules
Most predictive techniques to examine Upstream price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Upstream using various technical indicators. When you analyze Upstream charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Upstream Bio Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Upstream Bio's financial statements to predict how it will affect future prices.
Cash | First Reported 2010-12-31 | Previous Quarter 374.8 M | Current Value 393.5 M | Quarterly Volatility 136.9 M |
Upstream Bio Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Upstream Bio on the next trading day is expected to be 33.60 with a mean absolute deviation of 1.03, mean absolute percentage error of 1.60, and the sum of the absolute errors of 62.65.Please note that although there have been many attempts to predict Upstream Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Upstream Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Upstream Bio Stock Forecast Pattern
| Backtest Upstream Bio | Upstream Bio Price Prediction | Buy or Sell Advice |
Upstream Bio Forecasted Value
In the context of forecasting Upstream Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Upstream Bio's downside and upside margins for the forecasting period are 29.49 and 37.72, respectively. We have considered Upstream Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Upstream Bio stock data series using in forecasting. Note that when a statistical model is used to represent Upstream Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.5802 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0271 |
| MAPE | Mean absolute percentage error | 0.0374 |
| SAE | Sum of the absolute errors | 62.6507 |
Predictive Modules for Upstream Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Upstream Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Upstream Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Upstream Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Upstream Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Upstream Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Upstream Bio Estimiated After-Hype Price Volatility
In the context of predicting Upstream Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Upstream Bio's historical news coverage. Upstream Bio's after-hype downside and upside margins for the prediction period are 27.30 and 35.52, respectively. We have considered Upstream Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Upstream Bio is very steady at this time. Analysis and calculation of next after-hype price of Upstream Bio is based on 3 months time horizon.
Upstream Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Upstream Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Upstream Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Upstream Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.57 | 4.11 | 0.38 | 0.01 | 11 Events / Month | 8 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
31.79 | 31.41 | 1.20 |
|
Upstream Bio Hype Timeline
On the 23rd of January Upstream Bio is traded for 31.79. The entity has historical hype elasticity of -0.38, and average elasticity to hype of competition of 0.01. Upstream is projected to decline in value after the next headline, with the price expected to drop to 31.41. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -1.2%, whereas the daily expected return is at this time at 0.57%. The volatility of related hype on Upstream Bio is about 31615.38%, with the expected price after the next announcement by competition of 31.80. About 15.0% of the company outstanding shares are owned by insiders. The book value of Upstream Bio was at this time reported as 7.01. The company recorded a loss per share of 6.4. Upstream Bio had not issued any dividends in recent years. Considering the 90-day investment horizon the next projected press release will be in about 11 days. Check out Historical Fundamental Analysis of Upstream Bio to cross-verify your projections.Upstream Bio Related Hype Analysis
Having access to credible news sources related to Upstream Bio's direct competition is more important than ever and may enhance your ability to predict Upstream Bio's future price movements. Getting to know how Upstream Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Upstream Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZBIO | Zenas BioPharma Common | 0.04 | 9 per month | 11.21 | 0.02 | 13.19 | (8.49) | 84.91 | |
| NTLA | Intellia Therapeutics | 0.29 | 10 per month | 0.00 | (0.05) | 11.23 | (8.86) | 55.28 | |
| WVE | Wave Life Sciences | 0.31 | 8 per month | 4.20 | 0.09 | 8.92 | (8.08) | 164.47 | |
| RLAY | Relay Therapeutics | (0.21) | 11 per month | 3.21 | 0.05 | 6.11 | (5.45) | 27.25 | |
| PHVS | Pharvaris BV | 0.06 | 6 per month | 3.24 | 0.09 | 7.01 | (6.01) | 27.81 | |
| SNDX | Syndax Pharmaceuticals | 0.06 | 10 per month | 2.29 | 0.14 | 8.88 | (3.59) | 18.37 | |
| NVAX | Novavax | (0.11) | 10 per month | 2.55 | 0.06 | 6.60 | (5.06) | 17.41 | |
| AMLX | Amylyx Pharmaceuticals | 0.08 | 8 per month | 2.86 | 0.02 | 8.11 | (4.94) | 15.63 | |
| TERN | Terns Pharmaceuticals | (0.20) | 10 per month | 2.58 | 0.24 | 13.30 | (6.06) | 76.18 | |
| SYRE | Spyre Therapeutics | (0.19) | 11 per month | 2.23 | 0.17 | 7.15 | (3.87) | 20.03 |
Other Forecasting Options for Upstream Bio
For every potential investor in Upstream, whether a beginner or expert, Upstream Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Upstream Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Upstream. Basic forecasting techniques help filter out the noise by identifying Upstream Bio's price trends.Upstream Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Upstream Bio stock to make a market-neutral strategy. Peer analysis of Upstream Bio could also be used in its relative valuation, which is a method of valuing Upstream Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Upstream Bio Market Strength Events
Market strength indicators help investors to evaluate how Upstream Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Upstream Bio shares will generate the highest return on investment. By undertsting and applying Upstream Bio stock market strength indicators, traders can identify Upstream Bio entry and exit signals to maximize returns.
Upstream Bio Risk Indicators
The analysis of Upstream Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Upstream Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting upstream stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.33 | |||
| Semi Deviation | 3.18 | |||
| Standard Deviation | 4.3 | |||
| Variance | 18.53 | |||
| Downside Variance | 14.2 | |||
| Semi Variance | 10.11 | |||
| Expected Short fall | (3.86) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Upstream Bio
The number of cover stories for Upstream Bio depends on current market conditions and Upstream Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Upstream Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Upstream Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Upstream Bio Short Properties
Upstream Bio's future price predictability will typically decrease when Upstream Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Upstream Bio often depends not only on the future outlook of the potential Upstream Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Upstream Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.3 M | |
| Cash And Short Term Investments | 470.5 M |
Check out Historical Fundamental Analysis of Upstream Bio to cross-verify your projections. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.40) | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets | Return On Equity |
The market value of Upstream Bio is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio's value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio's market value can be influenced by many factors that don't directly affect Upstream Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.